Overall rank by patents
#38,817
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 12 technology areas, active 2018–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A23L (FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF).
The verdict
Agan holds 6 US patents across 12 technology areas, rank #38,817 of 50,000 tracked assignees.
Agan Aroma & Fine Chemicals Ltd. has been granted 6 US utility patents between 2018 and 2020, placing Agan Aroma & Fine Chemicals Ltd. at rank #38,817 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.5 claims per patent with primary concentration in A23L (FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF). As a Foreign Corporation, Agan Aroma & Fine Chemicals Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Agan sits between Aerovate Therapeutics, Inc. (6 patents, rank #38,813) and Ahram Biosystems, Inc. (6 patents, rank #38,821) - the closest US assignees by grant volume. The composite Innovation Score of 29.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 3 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Agan Aroma & Fine Chemicals Ltd.'s 17.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Agan Aroma & Fine Chemicals Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Aerovate Therapeutics, Inc.
6 patents
Affinity Labs of Texas, LLC
6 patents
Affinivax, Inc.
6 patents
Affle (India) Limited
6 patents
Agot Co.
6 patents
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
6 patents
AgroSpheres, Inc.
6 patents
Ahram Biosystems, Inc.
6 patents
Agan Aroma & fine chemicals Ltd.
6 patents
What this shows Agan holds 6 patents at rank #38,817, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #38,817 in granted patent volume.
Other assignees with the most granted patents in Agan's primary technology class.
Agan's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 69% higher than 31% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 16.7% |
| 2019 | 2 | 33.3% |
| 2020 | 3 | 50.0% |
Top 12 of 12 technology areas
Overall rank by patents
#38,817
Across all tracked assignees
29.5 out of 100
How to use this portfolio
Agan's 6 grants land it in the top 69% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.